Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Lei Nie
Assistant Professor
Lymphoma-Myeloma
https://orcid.org/0000-0001-6969-5013
h-index
2475
Citations
21
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2002
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(33)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Lei Nie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mantle Cell Lymphoma
100%
Triple-negative Breast Cancer
83%
Enhancer of Zeste Homolog 2 (EZH2)
80%
Cyclin-dependent Kinase 2 (CDK2)
60%
PARP Inhibitor (PARPi)
60%
Apoptosis
45%
Epidermal Growth Factor Receptor
43%
In Cancer
41%
Gasdermin C
40%
Site-specific Phosphorylation
40%
EIF3D
40%
Ibrutinib
35%
Bruton Tyrosine Kinase Inhibitor
35%
Lymphoma Cells
33%
Cyclin-dependent Kinase 9 (CDK9)
32%
Tumor Growth
27%
Basic Helix-loop-helix (bHLH)
27%
Phosphorylation
26%
Co-target
24%
Overcoming Resistance
24%
Breast Tumor
23%
Breast Cancer Cells
23%
S-phase Kinase-associated Protein 2 (Skp2)
22%
Inhibitor Resistance
22%
Ubiquitination
22%
Epidermal Growth Factor Receptor Inhibitors
22%
NF-B
21%
Cancer Cells
21%
Therapeutic Strategies
21%
Acquired Resistance
21%
Chemotherapy Resistance
21%
TAL1
20%
Glutaminase 1 (GLS1)
20%
MALT1
20%
MET Inhibitor
20%
GRK2
20%
BikDD
20%
Bruton's Tyrosine Kinase
20%
Target Molecule
20%
Gene Expression
20%
Pyroptosis
20%
H3K27me3
20%
Inhibit Tumor
20%
Pre-TCR
20%
Long ncRNAs
20%
Hematopoietic Stem Cells
20%
Spinocerebellar Ataxia
20%
Human Breast Cancer
20%
Constitutively Active
20%
Tumor Necrosis
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
68%
Ubiquitination
62%
EZH2
60%
Drive
60%
Notch
54%
Epidermal Growth Factor Receptor
50%
Phosphotransferase
42%
Kinase
42%
Transcription Factor EZH2
40%
Poly ADP Ribose Polymerase
40%
Ubiquitin Ligase
38%
Transcription
32%
Programmed Cell Death
30%
Cyclin-Dependent Kinase
26%
Ibrutinib
26%
Tyrosine Kinase Inhibitor
25%
Notch Signaling Pathway
25%
T Cell
25%
Gene Expression
24%
C-Terminus
22%
Cell Proliferation
22%
Glutaminase
20%
Pyroptosis
20%
Immune Evasion
20%
Cyclin-Dependent Kinase 2
20%
Green Fluorescent Protein
20%
PD-L1
20%
Ankyrin Repeat
20%
HDAC1
20%
Hematopoietic Cell
20%
Ankyrin
20%
Cyclin-Dependent Kinase 9
20%
Transcription Factor Nrf2
20%
Methylation
20%
STAT5
20%
Targeting Protein
20%
Long Non-Coding RNA
20%
Glycogen Synthase Kinase 3
20%
Stem Cell
20%
Deacetylation
20%
P-TEFb
20%
Rituximab
20%
calcium activated,phospholipid dependent protein kinase
20%
Growth Factor Receptor Inhibitor
20%
Glycosylation
20%
Interleukin 6
20%
Pi3K/Akt Signaling
20%
ADP-ribosylation
20%
Cell Migration
18%
Ubiquitin
17%
Medicine and Dentistry
Cancer Cell
72%
Triple Negative Breast Cancer
68%
Programmed Cell Death
62%
PARP Inhibitor
60%
Mantle Cell Lymphoma
60%
Breast Cancer
50%
Programmed Death-Ligand 1
40%
Tumor Necrosis
40%
Pyroptosis
40%
Epidermal Growth Factor Receptor
40%
Ibrutinib
36%
Mantle Cell Lymphoma Cell
35%
Cyclin-Dependent Kinase
26%
Poly ADP Ribose Polymerase
26%
Bruton Tyrosine Kinase Inhibitor
25%
Downregulation
24%
Ovarian Cancer
24%
Glutaminase
20%
Gallbladder Cancer
20%
Bruton Tyrosine Kinase
20%
Inhibitor of Apoptosis Protein
20%
Cancer
20%
Lung Cancer
20%
Cell Death
20%
Cytotechnology
20%
Transcription Factor EZH2
20%
Helix Loop Helix Protein
20%
Targeting Protein
20%
Drive
20%
Lymphocyte Development
20%
T Cell Receptor
20%
Epidermal Growth Factor Receptor Kinase Inhibitor
20%
Phosphotransferase
20%
Diseases
20%
calcium activated,phospholipid dependent protein kinase
20%
Adenosine Diphosphate Ribosylation
20%
Cell Signaling Pathway
20%
Tyrosine-Kinase Inhibitor
17%
PARP1
16%
Thymocyte
14%
Venetoclax
13%
Xenograft
12%
Double-Strand DNA Break
12%
BRCA1
10%
Glutamine
10%
Talazoparib
10%
Caspase 8
10%
Tumor Necrosis Factor
10%
T Cell Acute Lymphocytic Leukemia Protein 1
10%
In Vitro
9%
